BTLA and nonpapillary renal cell carcinoma: As reported by Cattrini et al. [40], AXL was significantly correlated with BTLA, CD244, CD274, CTLA4 and other immune checkpoint molecules in ccRCC, indicating the vital roles of AXL in immunotherapy.